Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/7/1/71/438915/7-1-71.pdf
Reference28 articles.
1. Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer;Soukop;Oncology,1992
2. Improved control of emesis and quality of life with ondansetron in breast cancer;Clavel;Oncology,1993
3. Emesis as limiting toxicity in cancer chemotherapy;Laszlo,1983
4. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy;Bonneterre;J Clin Oncol,1990
5. The role of ondansetron in the treatment of emesis induced by non-cisplatin containing chemotherapy;Schmoll;Eur J Cancer Clin Oncol,1989
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis;International Journal of Clinical Oncology;2020-11-08
2. Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2020-08
3. Dexamethasone-sparing regimen is an effective and safe alternative in overall antiemetic protection;Medicine;2019-09
4. Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting;Breast Cancer Research and Treatment;2016-01
5. Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer – An inspection of the evidence base informing clinical decision-making;Cancer Treatment Reviews;2015-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3